Categories
Health

Behind Biden’s Pledge to Share 80 Million Vaccine Doses

WASHINGTON – When an airliner carrying 2.5 million doses of the coronavirus vaccine took off from Moderna from Dallas to Islamabad, Pakistan on Wednesday, federal officials had just gone through a dizzying bureaucratic back and forth getting them there.

The United States had a donation agreement with Moderna and Covax, the longstanding vaccine exchange initiative. Covax had previously entered into indemnity agreements with Moderna that protect the company from liability for possible damage caused by the vaccine. Officials at the American embassy in Islamabad had worked with regulators there to assess the Food and Drug Administration’s review of the vaccine; Pakistani regulators had to sift through tons of materials on the vaccine batches and the factory that made them before approving their use there.

Once signed, the result was what is known as a tripartite agreement: a type of agreement that increasingly engages the Biden government’s pandemic response efforts and underscores how the demand for vaccines in the United States is lagging as many countries seek help ask of those who have a surplus.

Amid criticism from some public health experts that President Biden’s vaccine diplomacy has been slow and inadequate, the White House plans to announce Thursday that it has fulfilled the president’s pledge to distribute 80 million doses by June 30 around 50 countries, the African Union and the Caribbean consortium of 20 nations have been officially offered, with around half already delivered and the rest planned in the coming weeks, said Natalie Quillian, the Biden government’s deputy Covid-19 response coordinator .

The dose-sharing effort has become an ongoing activity across the federal government, with alternate-level meetings several times a week and daily operational reviews. The White House can hold up to 15 country-specific calls a day, starting at 7 a.m., often to the National Security Council, Centers for Disease Control and Prevention, the Department of State and Defense, and other agencies.

Approximately 75 percent of the doses are routed through Covax, which has delivered more than 91 million doses to both affluent and low-income countries. The rest is distributed through bilateral agreements that allow countries to retrieve and distribute cans more directly.

Researchers have estimated that 11 billion doses of vaccines are needed worldwide to potentially eradicate the coronavirus pandemic. In the past few months, tens of millions of doses of the three federally approved vaccines in the United States have gone unused, and more have come off the supply lines. White House officials said they wanted to ensure adequate supplies to Americans this spring before completing the overseas shipping overseas work.

To date, more than three billion vaccine doses have been administered worldwide, which is 40 doses per 100 people. Some countries have not yet reported a single dose, although the highly contagious Delta variant is spreading around the world, exposing other inequalities.

“If this is the pace at which it is continuing, then unfortunately it is much slower than necessary,” said Dr. Saad B. Omer, the director of the Yale Institute for Global Health, on the US effort.

Ms. Quillian said more doses would be shipped over the summer, in addition to the 500 million doses of the Pfizer BioNTech vaccine the Biden government promised this month to distribute to about 100 countries next year. She described this phase of vaccination diplomacy as procedurally more complex than the domestic vaccination program. Challenges with bilateral agreements, such as the three million doses of the Johnson & Johnson vaccine sent to Brazil last week, include: the recipient country is negotiating compensation agreements with the manufacturers.

When the cans destined for Pakistan were declared for shipping last week, attention shifted to packaging and transportation to the Dallas airport. The health authorities in Pakistan and an organization behind Covax – UNICEF, the United Nations Children’s Fund – will deliver it, an effort the Biden government wants to oversee. Less than two percent of the Pakistani population are fully vaccinated.

Dr. Hilary D. Marston, a member of the government’s Covid-19 Response Team and a former National Security Council and National Institutes of Health official who helped coordinate supplies, said the State Department and Centers for Control of Disease and Prevention had also worked with Pakistani officials to find out how many doses the country could store.

Pakistan is an obvious candidate for a vaccine donation, Ms. Quillian said. As a neighbor of India, which faced a devastating spike in virus cases this spring, Pakistan has likely been affected by the spread of the Delta variant, which was first identified in India. But the wider list of countries the United States has sent vaccines to required more consideration.

Updated

June 30, 2021, 6:05 p.m. ET

Jake Sullivan, the White House national security adviser, said at a news conference earlier this month that the government was initially prioritizing neighbors of the United States and Asian countries with spikes in virus cases.

The sharing of cans can sometimes appear to be an international matchmaking scheme. Some countries have requested the vaccine from Johnson & Johnson due to simpler storage requirements and its attractiveness as a one shot shot. Others have already approved one or more of the vaccines used in the US, which speeds up the process.

“Any country we offered a vaccine to,” said Ms. Quillian, “if they asked for a specific type, we were able to accommodate that request.”

Officials can still face significant hurdles. Since the donated cans were manufactured and sold according to American legal and official procedures, they must be approved separately by the recipient countries. The process often involves working out kinks with overseas regulators.

The use of Covax doses can sometimes stall, as in South Sudan and Congo, both of which put some of the initiative back due to logistical problems and vaccine reluctance. There have been clearer successes in bilateral agreements that the US has already negotiated. South Korea, which received a million doses of the Johnson & Johnson vaccine from the United States, reported that it used up 99.8 percent of the doses in just a few weeks, White House officials said.

Dr. Omer said that because of the time it takes vaccines to elicit an immune response, targeting donations to countries with outbreaks is insufficient.

“It has been six months, even since the vaccination program started, that we had some substantial movement on this issue,” he said of the dose-sharing campaign.

Ms. Quillian defended the government’s timing. “It’s hard to remember three months, or even February or January. We didn’t have enough vaccine for this country, ”she said. “The president wanted to make sure that we can take care of ourselves first and show that it can work here, and then we always wanted to share when we have surpluses.”

The government of Biden, said Dr. Omer said he needed to rely more on the CDC’s expertise in global vaccination campaigns, including its success in organizing the distribution of polio vaccines.

Dr. Michael H. Merson, professor of global health at Duke University and former director of the World Health Organization’s global program on AIDS, said a useful model for distributing vaccines overseas was the President’s Emergency Plan for AIDS Aid, or Pepfar. who worked with The Global Fund to provide, administer, and monitor the safety of antiretroviral drugs.

The CDC’s disease outbreak prediction operations recently received a financial boost from Mr Biden’s American rescue plan, which would enhance the White House’s efforts to identify potential virus hotspots overseas, White House officials said. A more organized program to do this work is underway, they said.

Categories
Politics

Home approves choose committee to analyze pro-Trump Capitol rebel

A supporter of U.S. President Donald Trump sprays smoke during a “Stop the Steal” protest outside of the Capitol building in Washington D.C. January 6, 2021.

Stephanie Keith | Reuters

The House passed legislation Wednesday that will form a select committee to investigate the violent Jan. 6 riot in which Donald Trump supporters stormed the U.S. Capitol. 

The measure passed in a 222-190 party-line vote. Only two Republicans, Reps. Adam Kinzinger, R-I.L., and Liz Cheney, R-W.Y., voted in favor of it.

 “We have the duty, to the Constitution and the Country, to find the truth of the January 6th Insurrection and to ensure that such an assault on our Democracy cannot happen again,” House Speaker Nancy Pelosi wrote in a letter to House members Wednesday morning. 

Pelosi announced the legislation after Senate Republicans blocked a bill in May that would have created an independent and bipartisan commission, modeled after the 9/11 commission, to probe the attack. GOP leaders asserted that it would only duplicate existing investigation efforts by the Justice Department and congressional committees. 

Under the newly approved legislation, the select committee will be led by Democrats and consist of 13 members. Pelosi will appoint one chairperson and all members to the committee, 5 of whom will be appointed in consultation with Republican House minority leader Kevin McCarthy, according to the legislation.  

The committee will investigate and report the facts and causes of the event, such as activities of intelligence and law enforcement agencies and technological factors that may have motivated the attack, the legislation says. It will also develop recommendations to prevent similar events from occurring in the future. 

All findings, conclusions and recommendations made by the committee will be issued in a final report to the House, according to the legislation. 

“Will we investigate how our democracy was attacked or will we send a green light to allow it to be attacked again? Will we stand with the cops or roll with the cop killers? Do we want the truth, or will we allow history to be erased? And are we for the constitution or are we for chaos?,” Representative Eric Swalwell said on the House floor.  

“January 6 was a crime against our democracy and the heroes of this Capitol. Now we must investigate it. Failing that, we are lawless. And lost.”

Rep. Michelle Fischbach, R-M.N., urged Republicans not to vote for the legislation, stating that it is “rife with partisan politics at its worst.”

A mob of Trump supporters stormed the Capitol on Jan. 6 in an effort to thwart Congress’ confirmation of President Joe Biden’s electoral victory. The attack left five people dead, including Capitol police officer Brian Sicknick. 

Pelosi invited Capitol Police Officer Harry Dunn and Metropolitan Police Officers Michael Fanone and Daniel Hodges to sit in during the House debate and vote. Gladys Sicknick, the mother of the police officer who died, was expected to attend as well. 

Police officers who responded at the Capitol and Gladys Sicknick have all lobbied for the independent select committee, the Associated Press reported Friday. 

Fanone and Dunn met with McCarthy last Friday, asking him to publicly condemn statements made by GOP members who have downplayed the attack and voted against honoring police for defending the Capitol, according to the Associated Press. 

Dunn, who had fought the rioters in hand-to-hand combat and was subject to racial slurs, told the Associated Press after the meeting that the goal is “accountability, justice for everybody that was involved.”

Fanone, who had described being shocked with a stun gun and beaten by rioters, added that he asked McCarthy not to put “the wrong people” on the select committee.

Categories
Health

CDC leaving it as much as states to set tips for masks, director says

Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention (CDC), takes off a protective mask during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Wednesday, May 19, 2021.

Greg Nash | Bloomberg | Getty Images

CDC Director Dr. Rochelle Walensky said Wednesday the U.S. agency is leaving it up to states and local health officials to set guidelines around mask-wearing even after the World Health Organization urged fully vaccinated people to continue the practice.

The Centers for Disease Control and Prevention has “always said that local policymakers need to make policies for their local environment,” Walensky said during an interview on the NBC program “TODAY.” She added that the agency’s guidelines broadly recommend that vaccinated people don’t need to wear masks.

“There are areas of this country where about a third of people are vaccinated, they have low vaccination rates,” Walensky said. “There are areas where they have more disease in the context of people not being vaccinated. So, in those areas, we’ve always said please look, make suggestions.”

She added, “If you are vaccinated, you are safe from the variants that are circulating here in the United States.”

The CDC director’s comments come days after WHO officials urged fully vaccinated people to continue to wear masks, social distance and practice other pandemic safety measures as the highly contagious delta variant spreads rapidly across the globe.

Delta, now in at least 92 countries, including the United States, is expected to become the dominant variant of the disease worldwide, according to the WHO. In the U.S., the prevalence of the strain is doubling about every two weeks.

WHO officials said Friday they are asking fully vaccinated people to continue to “play it safe” because a large portion of the world remains unvaccinated and highly contagious variants, like delta, are spreading in many countries and spurring outbreaks.

“People cannot feel safe just because they had the two doses. They still need to protect themselves,” Dr. Mariangela Simao, WHO assistant director-general for access to medicines and health products, said during a news briefing.

The WHO’s comments were a departure from the CDC, which has said fully vaccinated Americans can go maskless in most settings, and sparked widespread confusion.

Walensky said Wednesday that the WHO makes recommendations for a global population, adding many regions of the world remain unvaccinated.

“When the WHO makes those recommendations, they do so in that context,” she said.

Still, while many states have lifted most of their mask restrictions, places like Mississippi are recommending that residents continue to wear masks indoors even if they are fully vaccinated.

Delta is the dominant variant in Mississippi right now and only 31% of the state’s eligible population is vaccinated, state health officials said on a call late Tuesday. About 96% of new Covid cases are unvaccinated people, they added.

– CNBC’s Rich Mendez contributed to this report.

Categories
Entertainment

Britney Spears’s Father Requires Inquiry Into Singer’s Management Claims

James P. Spears, the father of Britney Spears and the man who has long played a leading role in overseeing his daughter’s affairs, on Tuesday called for an investigation into the singer’s allegations last week that she was molested under her supervision, including convicting them to carry out and take medication against their will.

The court records on behalf of Mr. Spears followed the singer’s first full public statement in 13 years about the complex legal regime that oversees her personal welfare and finances, calling for her to quit conservatory without undergoing a mental evaluation .

In her remarks at the June 23 hearing, broadcast in the courtroom and streamed online, Ms. Spears blamed her management team, janitors and family for their treatment, and made explicit mention of her father.

Now, Mr. Spears’ attorneys have requested an evidence hearing and challenged the actions of Ms. Spears’ current personal guardian and court appointed attorney, saying that “It is crucial that the court confirm that Ms. Spears’ testimony was correct or not “carefully to determine what corrective action, if any, needs to be taken.”

The filings, filed late Tuesday in Los Angeles and received by the New York Times, continued: “It is also imperative that all parties are given a full and fair opportunity to function properly in the Conservatory trial before this court Responding to allegations and claims. “Asserted against them.”

The twin-pronged conservatory, which manages Ms. Spears ‘personal life and estate, was first cleared by a probate court in Los Angeles in 2008 when Ms. Spears’ father moved for control of the singer’s business and welfare amid concerns regarding their mental health and their potential for substance abuse. The arrangement is usually reserved for people who cannot fend for themselves, although Ms. Spears continued to work and perform in the years that followed.

Mr. Spears is currently overseeing the singer’s finances, along with a corporate trustee whom Ms. Spears asked last year to join the arrangement. Her personal curator, Jodi Montgomery, temporarily took over from her father in September 2019 after Mr Spears resigned due to health issues.

But Ms. Spears’ recent statement, along with confidential court records obtained from the New York Times, revealed that in private Ms. Spears had consistently urged quitting conservatories, calling it “too, too much,” according to the Reported by a court investigator in 2016, adding that she was tired of being exploited.

In court last week, Ms. Spears called the setup abusive, likened it to sex trafficking, and described that in 2019 she was forced to tour, undergo psychiatric exams and take medication before her father gave up his role as her personal conservator.

She also said she could not remove her contraceptive even though she wanted to get married and have more children. Ms. Spears referred to her father as “the one who approved of everything”.

In a second filing on Tuesday, Mr. Spears’ attorneys denied the characterization that he was in command, arguing that Ms. Montgomery “has been fully responsible for the daily personal care and medical treatment of Ms. Spears” as of September 2019. , despite some allegations made by Ms. Spears prior to Ms. Montgomery’s appointment.

“Mr. Spears just is not involved in decisions related to Ms. Spears’ personal care or medical or reproductive problems,” his attorneys wrote. Spears cannot hear his daughter’s concerns and address them directly because he has been cut off from communicating with her. “

They added that Mr Spears had no intention of returning as his daughter’s personal curator, but said he was “concerned about the management and care of his daughter”.

Lauriann Wright, an attorney for Ms. Montgomery, said in a statement Wednesday that Ms. Montgomery, as a personal conservator, has been “a tireless advocate for Britney and her well-being” with “one primary goal – to support and encourage”. Britney on her way to no longer needing the person’s care. “

Ms. Wright pointed to Ms. Montgomery’s role as a “neutral decision maker in complex family dynamics” and said that Ms. Spears’ “decision to get married and have a family was never influenced by the Conservatory while Ms. Montgomery” was the Conservatory of the person. “

She added that Ms. Montgomery was looking forward to “finding a way to end the Conservatory.”

Mr. Spears attorneys also raised concerns about the role of Mrs. Spears’s court-appointed attorney, Samuel D. Ingham III, who was hired on the case in 2008 when the singer was deemed unable to choose her own representation.

In the documents, Mr. Spears’ attorneys asked if an earlier move to make the role of Ms. Montgomery permanent was what the singer wanted or even aware of, and found that “Ms. Spears has neither signed nor reviewed the petition to appoint her personal curator, “which was instead signed by Mr. Ingham.

Citing Mr. Ingham’s earlier claim that Ms. Spears was found to be unable to consent to medical treatment in 2014, they stated, “There has been no such finding and there is no such order.” This, too, requires an investigation in a subsequent hearing, the lawyers wrote.

When requesting an investigation, Mr. Spears’ attorneys said, “Either the allegations will turn out to be true and corrective action must be taken in this case, or they will be proven false, in which case the conservatory can continue.” It is unacceptable for restorers or the court to respond to Ms. Spears’ testimony. “

Previously, Ms. Spears had raised concerns about her father’s control over her, according to the investigator’s 2016 report. She cited her inability to make friends or to date without her father’s approval; the limits of her weekly allowance of $ 2,000, despite her success as a performer; and the fear and “very harsh” consequences she said are linked to conservatory violations, the investigator said.

At the time, the estate investigator concluded that the Conservatory was in Ms. Spears’ best interests because of her complex finances, vulnerability to outside influences, and “intermittent” drug problems, the report said. But it also called for “a path to independence and the eventual termination of the conservatory”.

Ms. Spears said in court last week that she did not know she could move to terminate the conservatories. “I’m sorry for my ignorance, but honestly I didn’t know,” she said.

Categories
World News

Dow rises almost 200 factors as Wall Road heads for profitable first half

U.S. stocks climbed near record highs on Wednesday as the market completed a successful first half and second quarter of 2021.

The Dow Jones Industrial Average rose around 190 points, boosted by strong days for Walmart and Boeing, while the S&P 500 was up 0.1%. The Nasdaq 100 lost around 0.1%.

Wednesday is the last day of the second quarter and the last day of the first half of 2021. At the start of the session, the S&P 500 was up 14% year-to-date, while the Nasdaq Composite and the Dow were both up 12%. For the quarter, the S&P 500 is up 8%. The S&P 500 and Nasdaq all posted new record closings on Tuesday.

The S&P 500 is heading for its fifth consecutive positive month, rising 2.1% to 4,291.80 in June. The broad index is also on track for its best first half since 2019.

Investors have shrugged off the high inflation readings and continued to buy stocks in hopes that an economic comeback for the pandemic would continue and that the Federal Reserve would for the most part maintain its loose policies. The top three Dow winners this year are Goldman Sachs, American Express, and Walgreens Boots Alliance, all of which are up more than 30%. Chevron, Microsoft, and JPMorgan Chase are each up more than 20%. The technology and health sectors of the S&P 500 both closed Tuesday with record highs.

The gains came as nearly 60% of adults in the US received a COVID-19 vaccine, which allows the economy to reopen quickly. Still, new variants of the virus have raised some concerns that other restrictions such as wearing masks would have to be reintroduced as the pace of vaccinations has slowed.

Investors have “a number of reasons to be constructive,” wrote Tom Lee, Managing Partner and Head of Research at Fundstrat Global Advisors, citing economic dynamism, strong credit markets and possible fiscal stimuli.

Lee raised his S&P 500 target for 2021 from 4,300 to 4,600 in a statement to his customers on Tuesday evening. The new forecast means a 7% gain from here.

Jeff Kilburg, chief investment officer at Sanctuary Wealth, told CNBC that he is optimistic for the second half of the year thanks to the Federal Reserve’s continued commitment to economic recovery.

“We can fight inflation what we want and we can fight over what metric to use for inflation, but I think at the end of the day we really see the Fed’s commitment,” Kilburg said, adding that The amount of investor money on the sidelines should keep minor pullbacks from turning into major corrections.

Some investors and strategists have cited the spread of the Delta variant of Covid-19 as a risk for the markets in the second half of the year. However, JPMorgan’s Marko Kolanovic said in a statement to clients on Wednesday that the variant shouldn’t hurt stock markets, citing low death rates in countries with widespread vaccination.

Good first halves for the market usually bode well for the rest of the year. Whenever there was double-digit growth in the first half of the year, the Dow and S&P 500 never ended this year with an annual decline, according to Refinitive data from 1950.

One group that helped the broader market to its latest record high are semiconductors. The VanEck Semiconductor Index has risen 6% since June 18 and more than 3% in the first two days of this week.

“Semis have recovered strongly and in the last two trading days have finally broken the downtrend that has existed since this high in mid-February. New highs and a broken downward trend? It’s been a big week for Semis. ”Bespoke Investment Group said in a statement to clients.

Pending home sales rose to their highest level since 2005 in May. However, mortgage demand fell last week, the Mortgage Bankers Association said on Wednesday, with high prices and low supply crowding out some potential buyers. The readings came after a spike in home prices, reflected in the S&P CoreLogic Case-Shiller Index, which drove homebuilders stocks up on Tuesday.

The Institute for Supply Management’s Chicago Purchasing Managers Index came in lower than expected in June but was still expanding.

During Tuesday’s regular session, stocks barely changed in light trading, although the S&P 500 hit its fourth straight session and an all-time high.

Stocks are unlikely to see much movement until Friday’s labor market report gives a better idea of ​​the state of the economy. According to a Dow Jones poll, economists expect 683,000 new jobs in June.

On Wednesday, payroll firm ADP reported that private payrolls rose 692,000 in June, exceeding expectations. However, the company’s May figure has been revised downwards.

– CNBC’s Robert Hum contributed to this report.

Categories
Health

Flip Your Telephone Right into a Health Coach

Ready to go outside and get fit this summer? The hardware of your smartphone, its software and an app store full of programs can help you with this. Here are instructions on how to get the most out of your device.

Remember that medical data is sensitive information. So, be sure to read the privacy policy of any app that tracks it or tracks you. Consult your doctor before making any major changes to your diet or exercise routine.

In 2014, Apple and Google announced both dashboard apps to track personal health and wellbeing, and the companies have improved these apps since then.

The Google Fit app works on the Android and iOS operating systems. (It can also import health data from Wear OS, Apple Watches, and third-party apps.) Working with the American Heart Association, Google Fit helps users set activity goals to collect Heart Points for better cardiovascular health. That year, Google announced that the app could also use the phone’s camera to measure heart and respiratory rates for informational purposes (but not as a medical diagnosis); Google’s own Pixel phones were the first to get this feature.

Both Apple Health and Google Fit include basic tools like a pedometer that uses the phone’s motion sensor to track your steps, but fitness and food apps can provide more detailed information.

If you’re looking for a workout app for a workout plan that goes beyond step counting, your options are plenty. Most of the popular programs are available for both Android and iOS. These include the Jefit Workout Planner and the Skimble Workout Trainer; Both offer instructions on specific exercises and routines for low subscription fees.

The Peloton app ($ 13 per month) offers video-controlled workouts, and Google Fit has a curated list of free workout videos on YouTube. For those in the Apple ecosystem, the Apple Fitness + service costs $ 10 per month and requires an Apple Watch with your iPhone to monitor your vital signs.

Recognition…overfly; Google

Runners and cyclists looking to measure their progress have a variety of apps to consider. For beginners, the $ 3 Couch to 5K app offers a workout plan for more stationary newbies to work their way up to a solid running routine. Runkeeper and MapMyRun use the phone’s location services to record and track routes; both are free with in-app purchases. Cyclemeter and Strava are also affordable apps that track running, cycling, and more.

If you want to focus on diet adjustments – eat more protein, consume less sodium, shed a few pandemic pounds – and don’t want to manually log food labels, consider a dedicated nutrition app. Many of these are free to download, but offer in-app subscriptions for personalized nutrition planning, community support, and other features.

Recognition…Lose it! / MyFitnessPal

Among the apps in this category is Lose It! focuses on calorie counting and weight loss and can share its data with Apple Health, Google Fit and other apps. Lose it! has a huge database of nutritional information for millions of items and can scan packaging labels to add new foods. MyFitnessPal is a similar program with a database of 11 million foods, a huge online community, and the ability to sync and share data with 50 other fitness apps and devices.

Your phone’s Maps app can help you get more active in general. For example, just type “gyms near me” to see where you can work out or “hike” to find hiking trails nearby.

Over the past year, both Apple Maps and Google Maps added new features for urban cyclists, including bike routes in specific cities, the location of bike rental docks in the city, and elevation information. In Google Maps for Android and iOS, you can also tap the Layers button to view bike routes and terrain – so you’re really prepared for any non-metaphorical climbs on your trip.

Categories
Politics

State Dept. Modifications Coverage for Passport Gender Identification

Americans are allowed to use their self-identified gender on their U.S. passports without presenting medical documents, under a new State Department rule announced by officials on Wednesday, the last day of Pride Month.

The shift was the first step in creating gender tagging on U.S. passports and citizenship certificates for individuals who identify as non-binary, intersex, or who otherwise do not conform to gender roles. This process is complex and will take time, said an official who spoke on condition of anonymity prior to Foreign Minister Antony J. Blinken’s announcement.

In the meantime, officials said, Americans who apply for a passport and proof of citizenship abroad will no longer be required to provide a medical certificate if their stated gender does not match their other identification documents.

The move fulfills an election promise made by President Biden, who has raised concerns that transgender and non-binary people without documented evidence of their self-identified gender are at risk of denial of employment, housing and other benefits, including the right to vote.

Blinken was expected to announce that the new policy will follow other countries that have taken similar steps – including Canada, Australia, Argentina, Nepal and New Zealand – to align in part with foreign allies and partners.

Currently, the State Department requires a medical certificate stating that a passport applicant has either moved or is in the process of changing their gender on official consular documents. It was not immediately clear on Wednesday when this requirement would no longer apply.

Last month the State Department reversed another policy that had disproportionately affected LGBTQ families and granted foreign-born babies US citizenship to married couples with at least one American parent, regardless of which parent was biological with the child was related.

This policy, a victory for same-sex couples, effectively guaranteed that American and binational couples who use assisted reproductive technology to give birth abroad – such as surrogate motherhood or sperm donation – can pass citizenship on to their children.

Categories
Health

How CRISPR gene enhancing will deal with illness: Intellia founder Doudna

The gene editing technology CRISPR reached an important milestone last weekend and completed its first systemic drug delivery to the human body.

CRISPR, or clustered, regularly spaced short palindromic repeats, cuts genomes and cuts DNA effectively to treat genetic diseases.

The latest breakthrough, the result of a study between biotech company Regeneron and Boston startup Intellia Therapeutics, treats a rare disease after it has been given as an IV infusion. Previously, other uses of CRISPR technology have been limited to ex vivo therapy, or where cells are removed from the body for genetic manipulation in a laboratory and then returned to the body.

Jennifer Doudna, who was awarded the Nobel Prize in Chemistry in 2020 for her work on CRISPR gene editing and is the co-founder of Intellia, recently told CNBC about the development of the technology from the publication of her early work to clinical studies showing its effectiveness at treating disease in less than 10 years means “one of the fastest rollouts in my opinion of technology from basic, initial science to actual application.”

“This is mainly because the technology comes at a time when there is a huge demand for genome editing and a lot of knowledge about genomes,” said Doudna at the recent CNBC Global Evolve Summit in mid-June.

As for next, Doudna highlighted several challenges and opportunities that CRISPR has on the horizon.

Deploying CRISPR remains a major challenge

As technology continues to advance, the task of getting the processed molecules in the body to the cells in the areas where they are needed remains a challenge.

“This is a particular issue in clinical medicine where the ability to manipulate brain cells, heart cells or muscle cells has incredible potential, but right now we don’t really have the tools to introduce the editors to those cells,” said Doudna. “We have the editors; we just don’t know how to get them where they need to go.”

Sickle cell anemia was an early focus

Much of the success of CRISPR’s previous applications has been in ex vivo therapy, in which extracted cells are manipulated in a laboratory and then returned to a patient.

Sickle cell anemia, which is genetically inherited and affects approximately 100,000 Americans, according to the CDC, was a particularly good target for the technology because blood stem cells “can be harvested, processed, and then returned to patients,” Doudna said.

Genetic eye diseases were also a focus for CRISPR applications, as Doudna said, “It is certainly easier to get into the eye than other parts of the body.”

The delivery of the processed cells to the liver has also proven to be easier so far. “A liver is an organ that naturally accepts molecules in the body,” she said.

Any advance in eradicating the 100+ liver diseases could have a huge impact on the lives of Americans. According to the American Liver Foundation, at least 30 million people, or one in ten Americans, have liver disease.

Next, let’s focus on the brain, heart, muscles

The next step for innovation around CRISPR will be to move these cells to other parts of the body like the brain, heart and muscles, Doudna said.

“There are already some technologies that make some of this possible, for example with different types of viruses or virus-like particles, and I look forward to the innovations that will come in this regard over the next few years,” she said.

Treatment costs are a problem

But as technology improves and scientists become able to fight disease throughout the body, Doudna said that CRISPR technology needs to be cheaper in order for it to have “widespread effects.”

Treating sickle cell anemia with CRISPR therapy costs about $ 2 million per patient, according to Doudna.

“That is clearly not a price point that makes this available to most of the people who can benefit from it,” she said.

While addressing delivery challenges can also help reduce costs, the medical community needs to figure out how “to scale molecule production so that we can cut costs,” said Doudna.

Applying CRISPR to Agriculture

The advancement of CRISPR technology may have an impact on other industries as well, with agriculture being one of the first to benefit.

Rather than addressing genetic problems through breeding, which can take months to years, or through current methods of genetically modifying crops that have seen a boom over the past few decades but that incorporate biological material from other species, CRISPR technology can address the Genes from plants “without touch” manipulate everything else, “said Doudna.

“This opens the door to a lot of things that can be done now to both address the challenges of climate change, manage drought, and introduce properties into the plants that will protect them from pests,” she said.

Categories
World News

Dwell Covid Information and Delta Variant Updates

Here’s what you need to know:

Credit…Rodrigo Paiva/Getty Images

The coronavirus has reversed a steady rise in life expectancy in Brazil, with an estimated decline of 1.3 years in 2020 and an even more accelerated drop during the first months of 2021, according to a new report published in the journal Nature Medicine.

Significant, abrupt declines in life expectancy are rare and Brazil’s represents a major blow given the strides the country had made in improving health outcomes in recent decades, said Marcia Castro, the chair of the Department of Global Health and Population at Harvard, the lead author of the study.

“We expect declines of this magnitude when you have a major shock that leads to high mortality, like a war or a pandemic,” she said.

Brazil has reported more than 514,000 deaths from Covid-19, an official death toll surpassed only by that in the United States, which has lost more than 604,000 people. Even so, the United States, which has a considerably larger population, experienced a slightly lower life-expectancy drop last year: 1.13 years.

The pandemic has continued to steadily worsen in Brazil, where vaccinations have lagged. At least 18 million Brazilians have been infected so far, or at least one in 11 people, and the country is averaging over 65,000 new reported cases and over 1,600 deaths a day, according to official data. But, as in India, which has the world’s third-largest official death toll, many experts believe the numbers understate the true scope of the country’s epidemic. So far, about a third of Brazil’s population has had at least one shot of a vaccine, according to Our World in Data.

The decline in life expectancy is a jarring setback for Brazil, Latin America’s largest nation, which has spent billions of dollars in recent decades to expand the reach and quality of its universal public health care system.

Between 1945 and 2020, life expectancy in Brazil increased from 45.5 years to 76.7 years, an average of about five months per year. The setbacks of the Covid-19 era have reverted the country to 2014 levels, according to the study.

Brazil experienced a second wave of coronavirus cases in the first few months of this year that has been far deadlier than the first one, which receded at the end of 2020.

Dr. Castro and fellow researchers estimated that the resulting decline in life expectancy for 2021, based on the death toll recorded in the first four months of the year, will be about 1.78 years.

States in the Amazon region — including Amazonas, Rondônia, Roraima and Mato Grosso — experienced the steepest declines in life expectancy last year. Dr. Castro said states in the northeast, where governors imposed relatively strict quarantine measures, experienced lower drops.

Dr. Castro said Brazil’s life expectancy rate was likely to decline even more as the virus continued to kill hundreds of people each day, many of whom are relatively young. The average daily death toll for the past week was 1,610, according to a New York Times tracker.

“The decline in 2021 is going to be just horrible,” Dr. Castro said. “We are now losing even younger people.”

Kim Jong-un during a meeting of North Korea’s Politburo on Tuesday, where he spoke of a “great crisis” in the country’s pandemic response.Credit…Korean Central News Agency/Korea News Service, via Associated Press

North Korea’s leader, Kim Jong-un, said that lapses in his country’s anti-pandemic campaign have caused a “great crisis” that threatened “grave consequences,” state media reported on Wednesday.

Mr. Kim did not clarify whether he was referring to an outbreak in North Korea, where the authorities had said there were no cases of the virus. But state media reported that the matter was serious enough for Mr. Kim to convene a meeting of the Political Bureau of his ruling Workers’ Party on Tuesday, during which Mr. Kim reshuffled the top party leadership.

Senior officials neglected implementing antivirus measures and had created “a great crisis in ensuring the security of the state and safety of the people,” Mr. Kim said.

Mr. Kim also berated party officials for their “ignorance, disability and irresponsibility,” said the official Korean Central News Agency.

A report said there would be some “legal” consequences for the officials.

The news agency said that some members of the Politburo and its Presidium, as well as some Workers’ Party secretaries, were replaced. In North Korea, all power is concentrated in the leadership of Mr. Kim, and he frequently reshuffles party officials and military leaders, holding them responsible for policy failures.

The North claims officially to be free of the virus, although outside experts remain skeptical, citing the country’s threadbare public health system and lack of extensive testing.

Still, North Korea has enforced harsh restrictions to contain transmission.

Last year, it created a buffer zone along the border with China, issuing a shoot-to-kill order to stop unauthorized crossings, according to South Korean and U.S. officials. South Korean lawmakers briefed by their government’s National Intelligence Service last year have said that North Korea executed an official for violating a trade ban imposed to fight the virus.

Last July, when a man from South Korea defected to the North, North Korea declared a national emergency for fear he might have brought the virus.

But Mr. Kim has also shown confidence that at least his inner circles were virus-free, sometimes presiding over meetings of party elites where no one wore masks.

During the meeting on Tuesday, Mr. Kim urged party officials to double down on his efforts to build a “self-reliant” economy. As North Korea’s economy has been hit hard by the pandemic, Mr. Kim has acknowledged that his five-year plan for growth had failed and instructed his officials to wage an “arduous march” through difficult economic times. This month, he warned of a looming food shortage.

The party meeting on Tuesday “suggests that the situation in the country has worsened beyond the capacity of self-reliance,” said Leif-Eric Easley, an associate professor of international studies at Ewha Womans University in Seoul.

“Pyongyang may be setting up a domestic political narrative to allow the acceptance of foreign vaccines and pandemic assistance,” he said. “Kim is likely to blame scapegoats for this incident, purging disloyal government officials and replacing them with others considered more capable.”

A vaccination center in New Delhi in May. The Delta variant was first identified in India and has reached at least 85 countries.Credit…Atul Loke for The New York Times

Last week, health officials announced that the Delta variant was responsible for about one in every five Covid-19 cases in the United States, and that its prevalence had doubled in the last two weeks.

First identified in India, Delta is one of several “variants of concern,” as designated by the Centers for Disease Control and Prevention and the World Health Organization. It has spread rapidly through India and Britain and poses a particular threat in places where vaccination rates remain low.

Here are answers to some common questions.

It’s not clear yet. “We’re hurting for good data,” said Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota.

But some evidence of a potential shift is emerging in Britain, where Delta has become the dominant variant.

“What we’ve noticed is the last month, we’re seeing different sets of symptoms than we were seeing in January,” said Tim Spector, a genetic epidemiologist at King’s College London, who leads the Covid Symptom Study, which asks people with the disease to report their symptoms in an app.

Headaches, a sore throat, and a runny nose are now among those mentioned most frequently, Dr. Spector said, with fever, cough and loss of smell less common.

These findings, however, have not yet been published in a scientific journal, and some scientists remain unconvinced that the symptom profile has truly changed. The severity of Covid, regardless of the variant, can vary wildly from one person to another.

Although there is not yet good data on how all of the vaccines hold up against Delta, several widely used shots, including those made by Pfizer, Moderna and AstraZeneca, appear to retain most of their effectiveness against the Delta variant, research suggests.

“If you’re fully vaccinated, I would largely not worry about it,” said Dr. Ashish K. Jha, dean of the Brown University School of Public Health.

Pockets of unvaccinated people, however, may be vulnerable to outbreaks in the coming months, scientists said.

“When you have such a low level of vaccination superimposed upon a variant that has a high degree of efficiency of spread, what you are going to see among under-vaccinated regions, be that states, cities or counties, you’re going to see these individual types of blips,” Dr. Anthony Fauci, the nation’s leading infectious disease expert, said on CNN on Tuesday. “It’s almost like it’s going to be two Americas.”

“Hamilton” qualified for millions under the federal Shuttered Venue Operators Grant program to help its five productions reopen.Credit…Cindy Ord/Getty Images

Until the pandemic shuttered all of its productions, “Hamilton” was making a lot of money: It has played to full houses since it opened in 2015, and on Broadway it has been seen by 2.6 million people and grossed $650 million.

So why is the show getting $30 million in relief from the federal government, with the possibility of another $20 million coming down the road?

The answer is that, before the pandemic, “Hamilton” had five separately incorporated productions running in the United States — one on Broadway and four on tour — and, under the rules set up for the government’s Shuttered Venue Operators Grant program, which provides pandemic relief for the culture sector and live-event businesses, each was eligible for $10 million to help make up for lost revenue.

“Remember when Chrysler and GM were about to go bankrupt? In the same way that the federal government came in to bail out auto companies, it’s doing the same thing for all of show business with this legislation,” said the show’s lead producer, Jeffrey Seller. “It’s returning us to health and it’s protecting the well-being of our employees.”

Seller said that none of the money would go to the show’s producers (including him) or its investors, and none would be used as royalties for artists (including the show’s creator, Lin-Manuel Miranda).

Instead, he said, the money will be used to remount the shuttered productions, and to reimburse the productions for pandemic-related expenses.

The rollout of the Shuttered Venue Operators Grant initiative, a $16 billion federal aid program designed to help get cultural organizations back on their feet after the pandemic forced many to close, has been plagued by delays and confusion. But the Small Business Administration, which is administering the program, has begun announcing grant recipients, and there are indications that Broadway and its affiliated businesses could fare well.

A Maricopa County constable signing an eviction notice in Phoenix last year.Credit…John Moore/Getty Images

The Supreme Court on Tuesday refused to lift a moratorium on evictions that had been imposed by the Centers for Disease Control and Prevention in response to the coronavirus pandemic.

The vote was 5 to 4, with Chief Justice John G. Roberts Jr. and Justices Stephen G. Breyer, Sonia Sotomayor, Elena Kagan and Brett M. Kavanaugh in the majority.

The court gave no reasons for its ruling, which is typical when it acts on emergency applications. But Justice Kavanaugh issued a brief concurring opinion explaining that he had cast his vote reluctantly and had taken account of the impending expiration of the moratorium.

“The Centers for Disease Control and Prevention exceeded its existing statutory authority by issuing a nationwide eviction moratorium,” Justice Kavanaugh wrote. “Because the C.D.C. plans to end the moratorium in only a few weeks, on July 31, and because those few weeks will allow for additional and more orderly distribution of the congressionally appropriated rental assistance funds, I vote at this time to deny the application” that had been filed by landlords, real estate companies and trade associations.

He added that the agency might not extend the moratorium on its own. “In my view,” Justice Kavanaugh wrote, “clear and specific congressional authorization (via new legislation) would be necessary for the C.D.C. to extend the moratorium past July 31.”

At the beginning of the pandemic, Congress declared a moratorium on evictions, which lapsed last July. The C.D.C. then issued a series of its own moratoriums.

“In doing so,” the challengers told the justices, “the C.D.C. shifted the pandemic’s financial burdens from the nation’s 30 to 40 million renters to its 10 to 11 million landlords — most of whom, like applicants, are individuals and small businesses — resulting in over $13 billion in unpaid rent per month.” The total cost to the nation’s landlords, they wrote, could approach $200 billion.

The moratorium defers but does not cancel the obligation to pay rent; the challengers wrote that this “massive wealth transfer” would “never be fully undone.” Many renters, they wrote, will be unable to pay what they owe. “In reality,” they wrote, “the eviction moratorium has become an instrument of economic policy rather than of disease control.”

In urging the Supreme Court to leave the moratorium in place, the government said that continued vigilance against the spread of the coronavirus was needed and noted that Congress had appropriated tens of billions of dollars to pay for rent arrears.

Categories
Health

Las vacunas de Pfizer y Moderna podrían generar una inmunidad duradera, según científicos

Las vacunas fabricadas por Pfizer-BioNTech y Moderna generan una reacción inmunitaria persistente en el organismo que puede proteger contra el coronavirus durante años, informó el lunes un grupo de científicos.

Los hallazgos se suman a la creciente evidencia de que la mayoría de las personas inmunizadas con las vacunas de ARNm podrían no necesitar refuerzos, siempre y cuando el virus y sus variantes no evolucionen mucho más allá de sus formas actuales, algo que no está garantizado. Es posible que las personas que se recuperaron de COVID-19 antes de ser vacunadas no necesiten refuerzos incluso si el virus realiza una transformación significativa.

“Es una buena señal de lo durable que es nuestra inmunidad proveniente de esta vacuna”, dijo Ali Ellebedy, inmunólogo de la Universidad de Washington en Saint Louis que dirigió el estudio, publicado en la revista Nature.

El estudio no incluyó a la vacuna fabricada por Johnson & Johnson, sin embargo, el doctor Ellebedy dijo que esperaba que la respuesta inmunitaria sea menos durable que la que producen las vacunas de ARN mensajero.

Ellebedy y sus colegas reportaron el mes pasado que en quienes sobreviven a la COVID-19, las células inmunitarias que reconocen al virus permanecen inactivas (durmientes) en la médula ósea durante al menos ocho meses después de la infección. Un estudio de otro equipo indicó que las llamadas células B de memoria siguen madurando y fortaleciéndose durante al menos un año tras la infección.

Los investigadores, con fundamento en esos hallazgos, sugirieron que la inmunidad podría durar por años y tal vez toda la vida en las personas que contrajeron el coronavirus y luego fueron vacunadas. Pero no quedó muy claro si es posible conseguir un efecto tan duradero solo con la vacunación.

El equipo de Ellebedy buscó resolver esa pregunta al examinar la fuente de las células de memoria: los nódulos linfáticos, donde las células inmunitarias se entrenan para reconocer y combatir el virus.

Después de una infección o la vacunación, se forma una estructura especializada llamada centro germinal en los ganglios linfáticos. Esta estructura es una suerte de escuela de élite para las células B, un campo de entrenamiento donde se vuelven cada vez más sofisticadas y aprenden a reconocer un conjunto diverso de secuencias genéticas virales.

Es más probable que estas células logren frustrar a las variantes del virus que puedan surgir si disponen de más tiempo y rango para practicar.

“Todos se enfocan siempre en la evolución del virus; esto muestra que las células B están haciendo lo mismo”, dijo Marion Pepper, inmunóloga de la Universidad de Washington en Seattle. “Y va a proteger contra la evolución en curso del virus, lo cual es realmente alentador”.

Después de contraer el coronavirus, se forma el centro germinal en los pulmones. Pero después de la vacunación, la educación de las células sucede en los nódulos linfáticos de las axilas, al alcance de los investigadores.

Ellebedy y sus colegas reclutaron a 41 personas, incluidas ocho con antecedentes de infección por el virus, que fueron inmunizadas con dos dosis de la vacuna Pfizer-BioNTech. De 14 de estas personas, el equipo extrajo muestras de los ganglios linfáticos a las tres, cuatro, cinco, siete y 15 semanas después de la primera dosis.

Ese laborioso trabajo es lo que hace que este sea un “estudio heróico”, comentó Akiko Iwasaki, inmunólogo de Yale. “Este tipo de análisis cuidadoso de series de tiempo en humanos es muy difícil de realizar”.

El equipo de Ellebedy encontró que a las 15 semanas de recibir la primera dosis de la vacuna, el centro germinal seguía altamente activo en los 14 participantes y que la cantidad de células de memoria capaces de reconocer al coronavirus no había disminuido.

“Que las reacciones continuaran casi cuatro meses después de la vacunación, es una señal muy muy buena”, comentó Ellebedy. Los centro germinales suelen tener su máxima expresión una o dos semanas después de la inmunización y luego declinan.

“Por lo general no suele quedar mucho después de cuatro a seis semanas”, dijo Deepta Bhattacharya, inmunólogo de la Universidad de Arizona. Pero los centros germinales estimulados por las vacunas de ARNm “siguen activas a los meses y no declinan mucho en la mayoría de las personas”.

Bhattacharya indicó que la mayor parte de lo que los científicos saben sobre la persistencia de los centros germinales proviene de la investigación con animales. El nuevo estudio es el primero en mostrar lo que sucede en las personas después de la vacunación.

Los resultados sugieren que una gran mayoría de las personas vacunadas estarán protegidas a largo plazo, al menos contra las variantes de coronavirus existentes. Pero los adultos mayores, las personas con sistemas inmunitarios débiles y aquellos que toman medicamentos inmunosupresores puede que necesiten refuerzos; Es posible que las personas que sobrevivieron a la COVID-19 y luego fueron inmunizadas nunca los necesiten.

Es difícil predecir con exactitud cuánto durará la protección de las vacunas de ARN mensajero. Si no existieran las variantes que esquivan a la inmunidad, esta podría durar en teoría toda la vida. Pero el virus claramente sigue evolucionando.

“Cualquier necesidad de un refuerzo sería a causa de una variante, no de un declive de la inmunidad”, dijo Bhattacharya. “No veo que eso llegue a suceder”.

Las personas que se infectaron con el coronavirus y luego se inmunizaron experimentan un aumento importante en sus niveles de anticuerpos, muy probablemente porque sus células B de memoria, que producen anticuerpos, tuvieron muchos meses para evolucionar antes de la vacunación.

La buena noticia: la vacuna de refuerzo probablemente tendrá el mismo efecto que una infección previa en personas inmunizadas, dijo Ellebedy. “Si les brindas otra oportunidad de participar, responderán de forma masiva”, dijo, refiriéndose a las células B de memoria.

En lo que respecta a reforzar el sistema inmunológico, la vacunación es “probablemente mejor” que recuperarse de la infección real, dijo. Otros estudios han sugerido que el repertorio de células B de memoria que se producen después de la vacunación es más diverso que el generado por la infección, lo que sugiere que las vacunas protegen mejor contra variantes que la inmunidad natural por sí sola.

Ellebedy dijo que los resultados también sugieren signos de una reacción inmunitaria persistente producidos por las vacunas de ARNm, en lugar de por aquellas más tradicionales, como la de Johnson & Johnson.

Pero esa es una comparación injusta, ya que la vacuna de Johnson & Johnson se administra en una sola dosis, dijo Iwasaki: “Es probable que si la J & J tuviera una segunda dosis, podría inducir el mismo tipo de respuesta”.

Apoorva Mandavilli es reportera del Times y se enfoca en ciencia y salud global. En 2019 ganó el premio Victor Cohn a la Excelencia en Reportaje sobre Ciencias Médicas. @apoorva_nyc